Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer Therapy
Cancer Biotherapy and Radiopharmaceuticals · 2025
DOI: 10.1089/cbr.2024.0143 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2025. Verfasst von Xinxin Hou und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine of Henan Polytechnic University, Jiaozuo, P.R. China. Hauptthemen laut MEDLINE: Hyaluronic Acid, Neoplasms, Drug Carriers, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Background
Hyaluronic acid (HA), as a critical ingredient of extracellular matrix (ECM) and synovial fluid, has attracted extensive attention in targeted tumor thearpy. The superiority of HA is reflected as its great biocompatibility, biodegradability and special binding ability to CD44 receptor. Moreover, CD44 receptor proteins are overexpressed in many kinds of tumor cells and cancer stem cells (CSCs). Therefore, HA is commonly used as ligands for the surface modification of versatile nanocarriers applied in various tumor therapy approaches.
Methods
We reviewed the literature and summarized the unique properties of HA, the rationale for the use of HA as tumor-specific carrier for drug delivery, catabolism of HA coated nanocarriers, and research achievements of frequently-used HA-modified organic and inorganic nanocarries.
Results
We concluded the significant applications of HA coated nanocarriers in tumor chemotherapy and chemoresistance, combination therapy and cancer theranostics.
Conclusion
The application prospect of HA-coated nanocarriers will be more extensive for various targeting combination therapy and theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine of Henan Polytechnic University, Jiaozuo, P.R. China.
- Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College North Sichuan Medical College, Sichuan, China.
ORCID-Profile: Xinxin Hou
Zitieren
APA
Hou, X., & Zhang, H. (2025). Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer Therapy. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0143
Vancouver
Hou X, Zhang H. Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer Therapy. Cancer Biotherapy and Radiopharmaceuticals. 2025. doi:10.1089/cbr.2024.0143
BibTeX
@article{Hou2025,
author = {Hou, Xinxin and Zhang, Hao},
title = {Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer Therapy},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2025},
doi = {10.1089/cbr.2024.0143}
}
EUVIMED